Viewing Study NCT00267657


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-01-04 @ 4:52 PM
Study NCT ID: NCT00267657
Status: UNKNOWN
Last Update Posted: 2017-01-11
First Post: 2005-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module